Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Related structures:
AlphaFold database: E9AWP5
Term | Name | Level | Count |
---|---|---|---|
GO:0001510 | RNA methylation | 4 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006396 | RNA processing | 6 | 2 |
GO:0006399 | tRNA metabolic process | 7 | 2 |
GO:0006400 | tRNA modification | 6 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008033 | tRNA processing | 8 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009451 | RNA modification | 5 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0030488 | tRNA methylation | 5 | 2 |
GO:0032259 | methylation | 2 | 2 |
GO:0034470 | ncRNA processing | 7 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0034660 | ncRNA metabolic process | 6 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043412 | macromolecule modification | 4 | 2 |
GO:0043414 | macromolecule methylation | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 13 |
GO:0005488 | binding | 1 | 13 |
GO:0008168 | methyltransferase activity | 4 | 13 |
GO:0008171 | O-methyltransferase activity | 5 | 13 |
GO:0008173 | RNA methyltransferase activity | 4 | 13 |
GO:0008175 | tRNA methyltransferase activity | 5 | 13 |
GO:0016740 | transferase activity | 2 | 13 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 13 |
GO:0043167 | ion binding | 2 | 13 |
GO:0043169 | cation binding | 3 | 13 |
GO:0046872 | metal ion binding | 4 | 13 |
GO:0062105 | RNA 2'-O-methyltransferase activity | 5 | 13 |
GO:0106050 | tRNA 2'-O-methyltransferase activity | 6 | 13 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 13 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 13 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 13 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 401 | 405 | PF00656 | 0.395 |
CLV_C14_Caspase3-7 | 41 | 45 | PF00656 | 0.472 |
CLV_C14_Caspase3-7 | 98 | 102 | PF00656 | 0.420 |
CLV_NRD_NRD_1 | 113 | 115 | PF00675 | 0.299 |
CLV_NRD_NRD_1 | 191 | 193 | PF00675 | 0.454 |
CLV_NRD_NRD_1 | 214 | 216 | PF00675 | 0.493 |
CLV_NRD_NRD_1 | 261 | 263 | PF00675 | 0.626 |
CLV_NRD_NRD_1 | 28 | 30 | PF00675 | 0.478 |
CLV_NRD_NRD_1 | 330 | 332 | PF00675 | 0.303 |
CLV_NRD_NRD_1 | 484 | 486 | PF00675 | 0.195 |
CLV_PCSK_FUR_1 | 259 | 263 | PF00082 | 0.606 |
CLV_PCSK_KEX2_1 | 113 | 115 | PF00082 | 0.299 |
CLV_PCSK_KEX2_1 | 191 | 193 | PF00082 | 0.480 |
CLV_PCSK_KEX2_1 | 214 | 216 | PF00082 | 0.493 |
CLV_PCSK_KEX2_1 | 261 | 263 | PF00082 | 0.626 |
CLV_PCSK_KEX2_1 | 330 | 332 | PF00082 | 0.304 |
CLV_PCSK_KEX2_1 | 484 | 486 | PF00082 | 0.195 |
CLV_PCSK_PC7_1 | 326 | 332 | PF00082 | 0.333 |
CLV_PCSK_SKI1_1 | 191 | 195 | PF00082 | 0.544 |
CLV_PCSK_SKI1_1 | 326 | 330 | PF00082 | 0.404 |
CLV_PCSK_SKI1_1 | 357 | 361 | PF00082 | 0.358 |
CLV_Separin_Metazoa | 251 | 255 | PF03568 | 0.554 |
CLV_Separin_Metazoa | 372 | 376 | PF03568 | 0.604 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.490 |
DOC_CKS1_1 | 139 | 144 | PF01111 | 0.272 |
DOC_PP1_RVXF_1 | 341 | 348 | PF00149 | 0.604 |
DOC_PP1_RVXF_1 | 476 | 482 | PF00149 | 0.448 |
DOC_PP2B_LxvP_1 | 177 | 180 | PF13499 | 0.508 |
DOC_PP2B_PxIxI_1 | 383 | 389 | PF00149 | 0.558 |
DOC_PP4_FxxP_1 | 139 | 142 | PF00568 | 0.420 |
DOC_USP7_MATH_1 | 151 | 155 | PF00917 | 0.386 |
DOC_USP7_MATH_1 | 209 | 213 | PF00917 | 0.490 |
DOC_USP7_MATH_1 | 232 | 236 | PF00917 | 0.552 |
DOC_USP7_MATH_1 | 307 | 311 | PF00917 | 0.460 |
DOC_USP7_MATH_1 | 447 | 451 | PF00917 | 0.536 |
DOC_USP7_MATH_1 | 472 | 476 | PF00917 | 0.479 |
DOC_USP7_MATH_1 | 77 | 81 | PF00917 | 0.707 |
DOC_WW_Pin1_4 | 138 | 143 | PF00397 | 0.460 |
DOC_WW_Pin1_4 | 497 | 502 | PF00397 | 0.488 |
LIG_14-3-3_CanoR_1 | 330 | 336 | PF00244 | 0.526 |
LIG_14-3-3_CanoR_1 | 346 | 352 | PF00244 | 0.551 |
LIG_14-3-3_CanoR_1 | 425 | 433 | PF00244 | 0.570 |
LIG_14-3-3_CanoR_1 | 457 | 463 | PF00244 | 0.479 |
LIG_14-3-3_CanoR_1 | 9 | 15 | PF00244 | 0.535 |
LIG_Actin_WH2_2 | 240 | 256 | PF00022 | 0.504 |
LIG_AP2alpha_2 | 303 | 305 | PF02296 | 0.400 |
LIG_APCC_ABBA_1 | 339 | 344 | PF00400 | 0.583 |
LIG_BIR_III_2 | 349 | 353 | PF00653 | 0.604 |
LIG_BIR_III_4 | 44 | 48 | PF00653 | 0.432 |
LIG_BIR_III_4 | 82 | 86 | PF00653 | 0.461 |
LIG_BRCT_BRCA1_1 | 16 | 20 | PF00533 | 0.428 |
LIG_Clathr_ClatBox_1 | 67 | 71 | PF01394 | 0.364 |
LIG_FHA_1 | 150 | 156 | PF00498 | 0.508 |
LIG_FHA_1 | 158 | 164 | PF00498 | 0.525 |
LIG_FHA_1 | 226 | 232 | PF00498 | 0.457 |
LIG_FHA_1 | 336 | 342 | PF00498 | 0.583 |
LIG_FHA_1 | 356 | 362 | PF00498 | 0.395 |
LIG_FHA_1 | 441 | 447 | PF00498 | 0.429 |
LIG_FHA_2 | 399 | 405 | PF00498 | 0.479 |
LIG_FHA_2 | 60 | 66 | PF00498 | 0.575 |
LIG_FHA_2 | 98 | 104 | PF00498 | 0.559 |
LIG_Integrin_RGD_1 | 42 | 44 | PF01839 | 0.470 |
LIG_Integrin_RGD_1 | 46 | 48 | PF01839 | 0.478 |
LIG_KLC1_Yacidic_2 | 400 | 404 | PF13176 | 0.479 |
LIG_LIR_Apic_2 | 136 | 142 | PF02991 | 0.445 |
LIG_LIR_Gen_1 | 143 | 151 | PF02991 | 0.264 |
LIG_LIR_Gen_1 | 219 | 227 | PF02991 | 0.405 |
LIG_LIR_Gen_1 | 418 | 426 | PF02991 | 0.594 |
LIG_LIR_Gen_1 | 432 | 442 | PF02991 | 0.395 |
LIG_LIR_Nem_3 | 143 | 149 | PF02991 | 0.266 |
LIG_LIR_Nem_3 | 219 | 223 | PF02991 | 0.426 |
LIG_LIR_Nem_3 | 225 | 230 | PF02991 | 0.440 |
LIG_LIR_Nem_3 | 418 | 423 | PF02991 | 0.594 |
LIG_LIR_Nem_3 | 432 | 437 | PF02991 | 0.395 |
LIG_PCNA_TLS_4 | 396 | 403 | PF02747 | 0.479 |
LIG_Pex14_1 | 16 | 20 | PF04695 | 0.398 |
LIG_Pex14_2 | 146 | 150 | PF04695 | 0.262 |
LIG_SH2_CRK | 434 | 438 | PF00017 | 0.437 |
LIG_SH2_SRC | 402 | 405 | PF00017 | 0.531 |
LIG_SH2_STAP1 | 12 | 16 | PF00017 | 0.300 |
LIG_SH2_STAP1 | 159 | 163 | PF00017 | 0.427 |
LIG_SH2_STAP1 | 227 | 231 | PF00017 | 0.377 |
LIG_SH2_STAT5 | 159 | 162 | PF00017 | 0.404 |
LIG_SH2_STAT5 | 182 | 185 | PF00017 | 0.436 |
LIG_SH2_STAT5 | 227 | 230 | PF00017 | 0.412 |
LIG_SH2_STAT5 | 402 | 405 | PF00017 | 0.488 |
LIG_SH2_STAT5 | 458 | 461 | PF00017 | 0.437 |
LIG_SH2_STAT5 | 487 | 490 | PF00017 | 0.497 |
LIG_SH2_STAT5 | 494 | 497 | PF00017 | 0.481 |
LIG_SH3_2 | 352 | 357 | PF14604 | 0.604 |
LIG_SH3_3 | 145 | 151 | PF00018 | 0.350 |
LIG_SH3_3 | 298 | 304 | PF00018 | 0.374 |
LIG_SH3_3 | 349 | 355 | PF00018 | 0.604 |
LIG_SH3_3 | 385 | 391 | PF00018 | 0.494 |
LIG_SH3_3 | 457 | 463 | PF00018 | 0.479 |
LIG_SUMO_SIM_par_1 | 222 | 229 | PF11976 | 0.436 |
LIG_WRC_WIRS_1 | 227 | 232 | PF05994 | 0.531 |
LIG_WRC_WIRS_1 | 78 | 83 | PF05994 | 0.572 |
MOD_CDK_SPK_2 | 497 | 502 | PF00069 | 0.488 |
MOD_CDK_SPxxK_3 | 497 | 504 | PF00069 | 0.513 |
MOD_CK1_1 | 398 | 404 | PF00069 | 0.472 |
MOD_CK1_1 | 416 | 422 | PF00069 | 0.381 |
MOD_CK1_1 | 452 | 458 | PF00069 | 0.497 |
MOD_CK1_1 | 54 | 60 | PF00069 | 0.608 |
MOD_CK2_1 | 458 | 464 | PF00069 | 0.539 |
MOD_CK2_1 | 97 | 103 | PF00069 | 0.345 |
MOD_GlcNHglycan | 126 | 129 | PF01048 | 0.532 |
MOD_GlcNHglycan | 133 | 136 | PF01048 | 0.502 |
MOD_GlcNHglycan | 196 | 200 | PF01048 | 0.526 |
MOD_GlcNHglycan | 367 | 370 | PF01048 | 0.404 |
MOD_GlcNHglycan | 408 | 411 | PF01048 | 0.317 |
MOD_GlcNHglycan | 415 | 418 | PF01048 | 0.309 |
MOD_GlcNHglycan | 87 | 90 | PF01048 | 0.667 |
MOD_GSK3_1 | 10 | 17 | PF00069 | 0.558 |
MOD_GSK3_1 | 318 | 325 | PF00069 | 0.588 |
MOD_GSK3_1 | 331 | 338 | PF00069 | 0.563 |
MOD_GSK3_1 | 47 | 54 | PF00069 | 0.554 |
MOD_GSK3_1 | 59 | 66 | PF00069 | 0.491 |
MOD_GSK3_1 | 87 | 94 | PF00069 | 0.592 |
MOD_LATS_1 | 27 | 33 | PF00433 | 0.351 |
MOD_N-GLC_1 | 429 | 434 | PF02516 | 0.309 |
MOD_N-GLC_2 | 106 | 108 | PF02516 | 0.275 |
MOD_N-GLC_2 | 49 | 51 | PF02516 | 0.556 |
MOD_N-GLC_2 | 503 | 505 | PF02516 | 0.383 |
MOD_NEK2_1 | 226 | 231 | PF00069 | 0.522 |
MOD_NEK2_1 | 335 | 340 | PF00069 | 0.604 |
MOD_NEK2_1 | 365 | 370 | PF00069 | 0.494 |
MOD_NEK2_1 | 87 | 92 | PF00069 | 0.490 |
MOD_NEK2_1 | 95 | 100 | PF00069 | 0.487 |
MOD_NEK2_2 | 151 | 156 | PF00069 | 0.387 |
MOD_NEK2_2 | 429 | 434 | PF00069 | 0.553 |
MOD_PIKK_1 | 472 | 478 | PF00454 | 0.479 |
MOD_PIKK_1 | 87 | 93 | PF00454 | 0.505 |
MOD_PKA_1 | 29 | 35 | PF00069 | 0.383 |
MOD_PKA_2 | 253 | 259 | PF00069 | 0.566 |
MOD_PKA_2 | 345 | 351 | PF00069 | 0.544 |
MOD_PKA_2 | 424 | 430 | PF00069 | 0.518 |
MOD_PKB_1 | 324 | 332 | PF00069 | 0.558 |
MOD_Plk_1 | 232 | 238 | PF00069 | 0.471 |
MOD_Plk_1 | 429 | 435 | PF00069 | 0.564 |
MOD_Plk_4 | 10 | 16 | PF00069 | 0.549 |
MOD_Plk_4 | 226 | 232 | PF00069 | 0.388 |
MOD_Plk_4 | 296 | 302 | PF00069 | 0.376 |
MOD_Plk_4 | 398 | 404 | PF00069 | 0.479 |
MOD_Plk_4 | 429 | 435 | PF00069 | 0.437 |
MOD_Plk_4 | 63 | 69 | PF00069 | 0.590 |
MOD_ProDKin_1 | 138 | 144 | PF00069 | 0.465 |
MOD_ProDKin_1 | 497 | 503 | PF00069 | 0.488 |
TRG_DiLeu_BaEn_1 | 219 | 224 | PF01217 | 0.480 |
TRG_DiLeu_BaEn_1 | 63 | 68 | PF01217 | 0.509 |
TRG_DiLeu_LyEn_5 | 219 | 224 | PF01217 | 0.480 |
TRG_ENDOCYTIC_2 | 11 | 14 | PF00928 | 0.437 |
TRG_ENDOCYTIC_2 | 227 | 230 | PF00928 | 0.377 |
TRG_ENDOCYTIC_2 | 434 | 437 | PF00928 | 0.437 |
TRG_ER_diArg_1 | 112 | 114 | PF00400 | 0.404 |
TRG_ER_diArg_1 | 191 | 193 | PF00400 | 0.513 |
TRG_ER_diArg_1 | 259 | 262 | PF00400 | 0.603 |
TRG_ER_diArg_1 | 324 | 327 | PF00400 | 0.496 |
TRG_ER_diArg_1 | 330 | 333 | PF00400 | 0.494 |
TRG_Pf-PMV_PEXEL_1 | 105 | 110 | PF00026 | 0.465 |
TRG_Pf-PMV_PEXEL_1 | 114 | 118 | PF00026 | 0.489 |
TRG_Pf-PMV_PEXEL_1 | 375 | 380 | PF00026 | 0.358 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0NJE0 | Trypanosomatidae | 33% | 100% |
A0A3Q8IG18 | Leishmania donovani | 52% | 100% |
A0A3S7WY71 | Leishmania donovani | 90% | 100% |
A4I0P4 | Leishmania infantum | 52% | 100% |
A4I0P5 | Leishmania infantum | 90% | 100% |
D0A723 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
E9AIR1 | Leishmania braziliensis | 79% | 100% |
E9AWP4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 53% | 94% |
Q4QAS6 | Leishmania major | 89% | 100% |
Q4QAS7 | Leishmania major | 52% | 94% |
V5BR90 | Trypanosoma cruzi | 35% | 96% |